Hepatitis C Support Group
Hepatitis C is a blood-borne viral disease which can cause liver inflammation, fibrosis, cirrhosis and liver cancer. The hepatitis C virus (HCV) is spread by blood-to-blood contact with an infected person's blood. Many people with HCV infection have no symptoms and are unaware of the need to seek treatment. Hepatitis C infects an estimated 150-200 million people worldwide.
Sofosbuvir is the just the first of a few all oral drugs going to FDA.
The others will go soon too and are effective for geno1 null responders as well.
They are all out there, it will just take about a year for them to come out.
Sofosbuvir will be used with Interferon and Ribavirin at first but then the rest will follow.
http://www.gilead.com/pr_1771657